We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




High-Sensitivity Troponin I Could Predict Preeclampsia in High-Risk Women

By LabMedica International staff writers
Posted on 16 Mar 2023

Pre-eclampsia is a dangerous pregnancy complication characterized by high blood pressure that complicates up to 8% of pregnancies, although data on biomarkers that can predict onset and disease severity has so far been limited. More...

Now, a new study has found High Sensitivity Cardiac Troponin I (hs-cTnI) to be significantly higher in pregnant women who go on to develop preeclampsia starting at 14 weeks.

The multi-center observational study by researchers at University Heart Center Freiburg (Freiburg, Germany) involved four international cohorts of pregnant women (SCOPE, MAViS, PRINCE, and OCC) and examined the relation between high-sensitivity troponin and pre-eclampsia onset and severity using the Abbott hs-cTnI assay. The preeclampsia definition varied based on cohort (PRINCE utilizing GSGO guidelines, MAViS and SCOPE utilizing ISSHP, and OCC utilizing DSOG). Severe preeclampsia was defined as preeclampsia requiring delivery <34 weeks gestation; high preeclampsia risk was defined as anyone meeting NICE guidelines for prophylactic aspirin.

A total of 2,293 pregnant women were included in the study, with 7.8% of them developing preeclampsia and 0.9% developing severe preeclampsia. Of the total, 17.3% were identified as high-risk prior to the start of the study, and the average age of the women was 32 years. Women who developed preeclampsia had a higher prevalence of hypertension, diabetes, African American ancestry, and a history of multiple pregnancies. hs-cTnI levels were persistently high in women who ultimately developed preeclampsia, starting from 14 weeks (and lasting up to 29 weeks) of gestational age (all p<0.001) in the women who ultimately developed preeclampsia (all p<0.001). A hs-cTnI cutoff value of >2.2pg/ml at 14 weeks and >2.6pg/ml at 26 weeks was found to have a combined 100% negative predictive value in predicting severe preeclampsia in women who had a high a priori risk (meeting NICE criteria). Additionally, a hs-cTnI cutoff value of >1.8pg/ml at 14 weeks and >1.9pg/ml at 26 weeks predicted the presence of any preeclampsia.

“Elevated levels of hs-cTnI may precede the development of preeclampsia….and may also have considerable potential in grading preeclampsia risk [and severity] in pregnant women…a randomized, prospective trial needs to assess the potential benefits,” stated Dr. Dirk Westermann from the University Heart Center Freiburg who led the research team.

Related Links:
University Heart Center Freiburg


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.